Cargando…
ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810449/ https://www.ncbi.nlm.nih.gov/pubmed/34705142 http://dx.doi.org/10.1245/s10434-021-11019-5 |
| _version_ | 1784644255515410432 |
|---|---|
| author | Alva-Ruiz, Roberto Truty, Mark J. |
| author_facet | Alva-Ruiz, Roberto Truty, Mark J. |
| author_sort | Alva-Ruiz, Roberto |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8810449 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88104492022-02-09 ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer Alva-Ruiz, Roberto Truty, Mark J. Ann Surg Oncol ASO Author Reflections Springer International Publishing 2021-10-27 2022 /pmc/articles/PMC8810449/ /pubmed/34705142 http://dx.doi.org/10.1245/s10434-021-11019-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | ASO Author Reflections Alva-Ruiz, Roberto Truty, Mark J. ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer |
| title | ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer |
| title_full | ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer |
| title_fullStr | ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer |
| title_full_unstemmed | ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer |
| title_short | ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer |
| title_sort | aso author reflections: neoadjuvant chemotherapy switch: optimizing neoadjuvant treatment sequencing in pancreas cancer |
| topic | ASO Author Reflections |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810449/ https://www.ncbi.nlm.nih.gov/pubmed/34705142 http://dx.doi.org/10.1245/s10434-021-11019-5 |
| work_keys_str_mv | AT alvaruizroberto asoauthorreflectionsneoadjuvantchemotherapyswitchoptimizingneoadjuvanttreatmentsequencinginpancreascancer AT trutymarkj asoauthorreflectionsneoadjuvantchemotherapyswitchoptimizingneoadjuvanttreatmentsequencinginpancreascancer |